ORCHID PHARMA LTD.

NSE : ORCHPHARMABSE : 524372ISIN CODE : INE191A01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE1091.551.4 (+0.13 %)
PREV CLOSE ( ) 1090.15
OPEN PRICE ( ) 1020.05
BID PRICE (QTY) 1089.15 (2)
OFFER PRICE (QTY) 1092.25 (16)
VOLUME 23555
TODAY'S LOW / HIGH ( )1020.05 1095.95
52 WK LOW / HIGH ( )371.2 1358.8
NSE1088.75-0.15 (-0.01 %)
PREV CLOSE( ) 1088.90
OPEN PRICE ( ) 1069.95
BID PRICE (QTY) 1088.95 (3)
OFFER PRICE (QTY) 1090.65 (3)
VOLUME 296939
TODAY'S LOW / HIGH( ) 1042.00 1096.70
52 WK LOW / HIGH ( )372.65 1359.95
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-07 1992
Management Info
Ram Gopal Agarwal - Chairman Manish Dhanuka - Managing Director
Registered Office

Address Orchid Towers,313 , Valluvar Kottam High Road,Nungambakkam,
Chennai,
Tamil Nadu-600034

Phone 044-28211000

Email corporate@orchidpharma.com / nikitak@orchidpharma.com

Website www.orchidpharma.com

Registrars Details
Abhipra Capital Ltd
Abhipra Complex,A-387 Azadpur,Dilkush Indl.Area G T Karnal Road ,New Delhi
Listing : BSE, NSE
NEWS
08Feb Orchid Pharma informs about outcome of
Orchid Pharma has informed that pursuant to Regulation 30 read Schedule..
31Jan Orchid Pharma informs about disclosure
In accordance to regulation 30 read with Part A of Schedule III of Secur..
27Dec Orchid Pharma informs about disclosures
Orchid Pharma has informed that the Exchange has received the disclosure..
26Dec Orchid Pharma informs about disclosure
Orchid Pharma has informed that it enclosed the disclosure under Regulat..
26Dec Orchid Pharma informs about disclosures
Orchid Pharma has informed that it enclosed the disclosure under Regulat..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit305.45541.89
Gross Profit 305.45 552.47
Operating Profit 433.511030.49
Net Sales 2205.916658.98
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 7147.55 (7.31%)
M.Cap (Rs. in Cr)9081.00
JB Chem & Pharma (BSE)
 1822.20 (1.21%)
M.Cap (Rs. in Cr)28381.25
Caplin Point Lab (BSE)
 1313.95 (1.60%)
M.Cap (Rs. in Cr)9960.52
Glaxosmithkline Phar (BSE)
 1903.20 (1.02%)
M.Cap (Rs. in Cr)32317.59
AMI Organics (BSE)
 1237.25 (1.34%)
M.Cap (Rs. in Cr)4577.98
Shareholding Pattern
PROMOTERS 69.84%
NON-INSTITUTION 11.53%
MUTUAL FUNDS/UTI 10.4%
FI/BANKS/INSURANCE 2.57%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.